PRUIX (PRUIX) Stock Price & Analysis
PRUIX (PRUIX) fell 0.25% to USD 192.1 as of June 10, 2026 at 05:02 UTC, according to Nexqual real-time market data.
PRUIX last closed at USD 192.59; the session ranged USD 192.1–192.1 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 157.38–197.83 (NAS). Source: Nexqual, June 10, 2026 at 05:02 UTC.
Key Statistics (as of June 10, 2026 at 05:02 UTC)
| Price | USD 192.1 |
|---|---|
| Change | ▼ 0.25% (down) |
| Previous Close | USD 192.59 |
| Open | USD 192.1 |
| Day Range | USD 192.1 – 192.1 |
| 52-Week Range | USD 157.38 – 197.83 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRUIX)
Nexqual's technical model rates PRUIX "NEUTRAL" based on 3 bullish and 2 bearish signals across 123 daily candles, as of June 10, 2026 at 05:02 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.27 (neutral) |
| vs SMA50 | Above (USD 186.35) |
| MACD | 2.19 (positive) |
Financial Health Score (PRUIX)
Nexqual rates PRUIX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:02 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRAIX | T. Rowe Price Capital Appreciat | USD 37.25 | ▲ 0.19% |
| PDGIX | T. Rowe Price Dividend Growth F | USD 87.21 | ▲ 0.43% |
| RPTIX | T. Rowe Price Mid-Cap Growth Fu | USD 99.16 | ▲ 0.97% |
| THISX | T. Rowe Price Health Sciences F | USD 83.07 | ▲ 1.39% |
| TTMIX | T. Rowe Price Communications & | USD 131.06 | ▲ 0.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:02 UTC. This page is informational and not investment advice.